2014 looks to be another exciting year for the U.S. generics drug industry, with plenty of developments already taking shape. Here are a few thoughts from your Thomson Reuters Generics research team based on the most significant events ahead. Download the Movers and Shakers quarterly report here. We could see generic launches of several top-selling […]
written on 13.03.2014